Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis have?
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis has 2,749 citations in the OpenAlex counts ScholarIQ stores.
When was Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis published?
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis has 2010 year in the ScholarIQ index.
What is the open-access status of Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis?
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis has bronze oa status in the ScholarIQ index.
What is the DOI of Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis?
The DOI for Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis is on the source record.
What is the PMID of Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis?
The PMID for Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis is on the source record.
What is the OpenAlex record for Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis?
The OpenAlex for Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis is on the source record.